Matches in SemOpenAlex for { <https://semopenalex.org/work/W3141437108> ?p ?o ?g. }
- W3141437108 endingPage "115" @default.
- W3141437108 startingPage "110" @default.
- W3141437108 abstract "The choice of an optimal antiretroviral therapy (ART) in naive patients presenting late for initial therapy with advanced HIV infection, that is, with a CD4 cell count <200/μL and/or an AIDS-defining disease (late presenters, LPs), is still a challenge, even for HIV specialists. At present, there is little information on the decision process and selection criteria that physicians must take into account when choosing the presumably optimal initial ART for LPs. This study analyzes reasons for the individual choice of first-line ART in HIV LPs. We conducted a prospective multi-center study to analyze the decision-making process of physicians treating naive HIV patients presenting with a CD4 cell count <200/μL and/or an AIDS-defining condition. Two European HIV treatment centers based in Frankfurt (Germany) and A Coruna (Spain) participated in the study. Physicians documented the reasons that led to their decision for a specific first-line ART regimen. A questionnaire was designed for the study. Decisions of the participating physicians were evaluated. A total of 52 treatment decisions were analyzed. Evaluation of the choice of antiretroviral treatment demonstrated that for the overall group of physicians, simplicity of the regimen was the most important selection criterion in 34.6% of cases. The presence of comorbidities was given as the decisive selection criterion in 26.9%, followed by experience with the chosen drugs in 21.2% of cases. In the group of physicians choosing an integrase strand transfer inhibitor (INSTI)-based regimen for first-line ART, the same selection criteria were identified as in the overall group; 33.3% of clinicians selected an INSTI-based regimen because of its simplicity. The presence of comorbidities was the second most frequent decisive criterion (31.0%), followed by personal experience with the prescribed ART (23.8%). In the protease inhibitor group, simplicity was also the most common selection criterion with 40%. Results of clinical trials were stated as the most important criterion for the selection of ART in 38% of all cases, followed by the expected adherence of the patient (22%). Among the physicians who used a non-nucleoside reverse transcriptase inhibitor-based regimen, patients' desire to have children was the most frequent criterion for selection of ART (60%). An ongoing pregnancy was the second most frequent selection criterion, followed by ART's simplicity (8%). For patients treated with a single-tablet regimen, simplicity of ART was comprehensibly the most important decisive criterion (54.5%). Experience with the chosen drugs was the decisive selection criterion in 24.2%, followed by comorbidities in 18.2% of cases. Physicians' selection of individual ART in patients presenting late for first-line treatment seems to be predominantly dependent on patient-centered factors such as adherence issues as well as the clinical experience of physicians with the prescribed drugs." @default.
- W3141437108 created "2021-04-13" @default.
- W3141437108 creator A5008932748 @default.
- W3141437108 creator A5010519076 @default.
- W3141437108 creator A5021477635 @default.
- W3141437108 creator A5028185132 @default.
- W3141437108 creator A5030943230 @default.
- W3141437108 creator A5036522089 @default.
- W3141437108 creator A5043298039 @default.
- W3141437108 creator A5047626680 @default.
- W3141437108 creator A5050955873 @default.
- W3141437108 creator A5062723924 @default.
- W3141437108 creator A5065285414 @default.
- W3141437108 creator A5070006495 @default.
- W3141437108 date "2021-04-01" @default.
- W3141437108 modified "2023-10-16" @default.
- W3141437108 title "Reasons for Choice of Antiretroviral Regimens in HIV Patients Presenting Late for Initial Treatment in Europe" @default.
- W3141437108 cites W1961258527 @default.
- W3141437108 cites W1979060754 @default.
- W3141437108 cites W1988226703 @default.
- W3141437108 cites W2019690398 @default.
- W3141437108 cites W2021462937 @default.
- W3141437108 cites W2032623485 @default.
- W3141437108 cites W2109664496 @default.
- W3141437108 cites W2553355845 @default.
- W3141437108 cites W2560190802 @default.
- W3141437108 cites W2617723976 @default.
- W3141437108 cites W2745285679 @default.
- W3141437108 cites W2807931585 @default.
- W3141437108 cites W2883179103 @default.
- W3141437108 cites W2891079110 @default.
- W3141437108 cites W2901639534 @default.
- W3141437108 cites W2963164305 @default.
- W3141437108 cites W3005571016 @default.
- W3141437108 cites W3037589573 @default.
- W3141437108 cites W3092287618 @default.
- W3141437108 doi "https://doi.org/10.1089/apc.2021.0011" @default.
- W3141437108 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33835853" @default.
- W3141437108 hasPublicationYear "2021" @default.
- W3141437108 type Work @default.
- W3141437108 sameAs 3141437108 @default.
- W3141437108 citedByCount "8" @default.
- W3141437108 countsByYear W31414371082022 @default.
- W3141437108 countsByYear W31414371082023 @default.
- W3141437108 crossrefType "journal-article" @default.
- W3141437108 hasAuthorship W3141437108A5008932748 @default.
- W3141437108 hasAuthorship W3141437108A5010519076 @default.
- W3141437108 hasAuthorship W3141437108A5021477635 @default.
- W3141437108 hasAuthorship W3141437108A5028185132 @default.
- W3141437108 hasAuthorship W3141437108A5030943230 @default.
- W3141437108 hasAuthorship W3141437108A5036522089 @default.
- W3141437108 hasAuthorship W3141437108A5043298039 @default.
- W3141437108 hasAuthorship W3141437108A5047626680 @default.
- W3141437108 hasAuthorship W3141437108A5050955873 @default.
- W3141437108 hasAuthorship W3141437108A5062723924 @default.
- W3141437108 hasAuthorship W3141437108A5065285414 @default.
- W3141437108 hasAuthorship W3141437108A5070006495 @default.
- W3141437108 hasConcept C126322002 @default.
- W3141437108 hasConcept C142462285 @default.
- W3141437108 hasConcept C154945302 @default.
- W3141437108 hasConcept C2781413609 @default.
- W3141437108 hasConcept C2993143319 @default.
- W3141437108 hasConcept C2993493390 @default.
- W3141437108 hasConcept C3013748606 @default.
- W3141437108 hasConcept C3019258254 @default.
- W3141437108 hasConcept C41008148 @default.
- W3141437108 hasConcept C512399662 @default.
- W3141437108 hasConcept C71924100 @default.
- W3141437108 hasConcept C81917197 @default.
- W3141437108 hasConceptScore W3141437108C126322002 @default.
- W3141437108 hasConceptScore W3141437108C142462285 @default.
- W3141437108 hasConceptScore W3141437108C154945302 @default.
- W3141437108 hasConceptScore W3141437108C2781413609 @default.
- W3141437108 hasConceptScore W3141437108C2993143319 @default.
- W3141437108 hasConceptScore W3141437108C2993493390 @default.
- W3141437108 hasConceptScore W3141437108C3013748606 @default.
- W3141437108 hasConceptScore W3141437108C3019258254 @default.
- W3141437108 hasConceptScore W3141437108C41008148 @default.
- W3141437108 hasConceptScore W3141437108C512399662 @default.
- W3141437108 hasConceptScore W3141437108C71924100 @default.
- W3141437108 hasConceptScore W3141437108C81917197 @default.
- W3141437108 hasIssue "4" @default.
- W3141437108 hasLocation W31414371081 @default.
- W3141437108 hasOpenAccess W3141437108 @default.
- W3141437108 hasPrimaryLocation W31414371081 @default.
- W3141437108 hasRelatedWork W2138131550 @default.
- W3141437108 hasRelatedWork W2148977521 @default.
- W3141437108 hasRelatedWork W2328581496 @default.
- W3141437108 hasRelatedWork W2367167160 @default.
- W3141437108 hasRelatedWork W2414351520 @default.
- W3141437108 hasRelatedWork W2613384466 @default.
- W3141437108 hasRelatedWork W2742203771 @default.
- W3141437108 hasRelatedWork W2756780913 @default.
- W3141437108 hasRelatedWork W2936279454 @default.
- W3141437108 hasRelatedWork W4300092925 @default.
- W3141437108 hasVolume "35" @default.
- W3141437108 isParatext "false" @default.
- W3141437108 isRetracted "false" @default.